Cambridge Heart enters agreement with EO Medical for MTWA technology

[News]

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.

More... (http://www.news-medical.net/news/20110922/Cambridge-Heart-enters-agreement-with-EO-Medical-for-MTWA-technology.aspx)